LENZ Therapeutics, Inc. (NASDAQ:LENZ – Free Report) – Equities research analysts at Leerink Partnrs issued their Q1 2024 earnings per share (EPS) estimates for shares of LENZ Therapeutics in a research report issued on Monday, April 15th. Leerink Partnrs analyst M. Goodman forecasts that the company will post earnings per share of ($0.51) for the
Malibu Boats (NASDAQ:MBUU – Free Report) had its target price cut by B. Riley from $45.00 to $39.00 in a research report sent to investors on Tuesday morning, Benzinga reports. They currently have a neutral rating on the stock. Several other equities research analysts also recently issued reports on the company. Raymond James downgraded Malibu
DA Davidson reissued their buy rating on shares of Euronet Worldwide (NASDAQ:EEFT – Free Report) in a report published on Monday morning, Benzinga reports. DA Davidson currently has a $126.00 price objective on the business services provider’s stock. EEFT has been the topic of a number of other research reports. StockNews.com raised Euronet Worldwide from